InterCure Ltd. (INCR)
NGM · Healthcare · Drug Manufacturers - Specialty & Generic
$0.87
+0.34%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$47.8M
Shares Outstanding
54.7M
Exchange
NGM
Currency
USD
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 388.7M | 355.6M | 238.8M | 270.2M |
| Gross Profit | 155.1M | 105.1M | 30.2M | 33.2M |
| Operating Income | 41.2M | 37.6M | -45.1M | 6.7M |
| Net Income | 44.8M | -62.0M | -67.8M | -35.7M |
| Diluted EPS | $0.99 | $-1.36 | $nan | $nan |